Karl S. Burgoyne, MD
- 2Articles
- 5.2KReads
- 1999–2013Active
- 15Collaborators
- 39Citations
About
Karl S. Burgoyne, MD, has published research on major depressive disorder and schizophrenia/schizoaffective disorders. His work includes studies on quantitative electroencephalogram biomarkers for predicting remission in major depression and the use of olanzapine following clozapine-induced granulocytopenia. Burgoyne's articles appeared in Psychiatrist.com publications between 1999 and 2013.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
